MedPath

Validation of a Brain-Computer Interface for Stroke Neurological Upper Limb Rehabilitation

Not Applicable
Completed
Conditions
Stroke, Ischemic
Stroke
Interventions
Device: Sham Brain-Computer Interface
Device: Brain-Computer Interface
Registration Number
NCT04724824
Lead Sponsor
Instituto Nacional de Rehabilitacion
Brief Summary

The study's main goal is to determine if clinical and physiological effects of a brain-computer interface intervention for the neurorehabilitation of stroke patients' upper limb are greater than the effects of a sham robotic feedback. For this purpose a randomized controlled trial will be performed to compare somatosensory sham robotic feedback with the same somatosensory feedback controlled with the brain-computer interface output.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Clinical diagnosis of first ischemic stroke
  • Time since stroke onset higher than 3 months and lower than 24 months
  • Hand paresis
  • Normal or corrected to normal vision
  • Without previous diagnosed neurological diseases
Exclusion Criteria
  • Clinical diagnosis of severe aphasia
  • Clinical diagnosis of severe depression
  • Clinical diagnosis of severe attention deficits
  • Previous diagnosis of traumatic brain injury
  • Previous diagnosis of spinal cord injury
  • Previous diagnosis of peripheral nerve injury

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham Brain-Computer Interface controlled robotic feedbackSham Brain-Computer Interface-
Brain-Computer Interface controlled robotic feedbackBrain-Computer Interface-
Primary Outcome Measures
NameTimeMethod
Mean change from baseline in upper limb motor function on the Fugl-Meyer Assessment for the Upper ExtremityAt enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset

Analysis of changes on the Fugl-Meyer Assessment for the Upper Extremity will reveal if there is a clinical significant sensorimotor function compared to baseline

Mean change from baseline in upper limb motor function on the Action Research Arm TestAt enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset

Analysis of changes on the Action Research Arm Test will reveal if there is a clinical significant motor function compared to baseline

Secondary Outcome Measures
NameTimeMethod
Mean change from baseline in corticospinal excitability measured with Transcranial Magnetic StimulationAt enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset

Motor Evoked Potentials parameters will reveal if there are changes of corticospinal excitability in both hemibodies compared to baseline

Mean change from baseline in cortical activity measured with Functional Magnetic Resonance ImagingAt enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset

Blood-oxygen-level-dependent imaging will be analyzed to assess if there are changes in cortical activity compared to baseline.

Mean change from baseline in grip strength measured with a dynamometerAt enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset

Analysis of hand strength measurements will reveal if there were changes compared to baseline

Trial Locations

Locations (1)

Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra (National Institute of Rehabilitation)

🇲🇽

Tlalpan, Mexico City, Mexico

© Copyright 2025. All Rights Reserved by MedPath